OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
MNG59

M&G PLC

Life & Health InsuranceVerified

M&G PLC has a liquidity position that is characterized by a debt-to-equity ratio of 2.19, indicating a relatively high leverage position. The company's cash and equivalents amount to 4.52 billion GBP, but this is offset by long-term debt of 6.87 billion GBP, resulting in a net cash position that is negative after subtracting total debt. The free cash flow for the period is negative at -174 million GBP, which suggests that the company is investing in its operations or facing operational cash outflows. In terms of profitability, M&G PLC's return on equity is 9.63%, which is a measure of how effectively the company is using shareholders' equity to generate profits. The return on assets is 0.16%, indicating that the company is generating a very low return on its total assets. These figures should be compared against the industry's preferred metrics and cohort medians to assess the company's performance relative to its peers. The company's revenue is not explicitly broken down by segments or geographic regions in the provided data, but the business is primarily focused on life and health insurance products. The lack of detailed segment information limits the ability to assess the diversification of the company's revenue streams and its exposure to different markets. The growth trajectory of M&G PLC is not clearly defined in the provided data, but the company's operating income of 1.43 billion GBP and net income of 302 million GBP suggest a stable performance. Analysts have provided a range of price targets, with a mean of 300.53 GBP and a median of 295.00 GBP, indicating a generally positive outlook. The mean recommendation of 2.50 suggests a mixed sentiment among analysts, with a balance of buy, hold, and strong-buy ratings. The risk assessment for M&G PLC indicates a medium liquidity risk and a low dilution risk. The company's capital structure, with a high debt-to-equity ratio, may pose a challenge in maintaining financial flexibility, especially in a volatile market environment. The risk of dilution is considered low, which is a positive sign for shareholders. Recent events and filings have not been detailed in the provided data, but the company's financial performance and analyst ratings suggest that it is maintaining a stable position in the market. The company's ability to manage its debt and maintain a positive operating income will be key factors in its future performance.

30-day price · MNG+18.80 (+6.3%)
Low$290.00High$318.30Close$315.70As of26 May, 00:00 UTC
Profile
CompanyM&G PLC
TickerMNG.L
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. M&G PLC provides life and health insurance products and services in the United Kingdom and internationally.

Classification. M&G PLC is classified under the Life & Health Insurance industry within the Insurance business sector, with a classification confidence of 0.92.

M&G PLC has a liquidity position that is characterized by a debt-to-equity ratio of 2.19, indicating a relatively high leverage position. The company's cash and equivalents amount to 4.52 billion GBP, but this is offset by long-term debt of 6.87 billion GBP, resulting in a net cash position that is negative after subtracting total debt. The free cash flow for the period is negative at -174 million GBP, which suggests that the company is investing in its operations or facing operational cash outflows. In terms of profitability, M&G PLC's return on equity is 9.63%, which is a measure of how effectively the company is using shareholders' equity to generate profits. The return on assets is 0.16%, indicating that the company is generating a very low return on its total assets. These figures should be compared against the industry's preferred metrics and cohort medians to assess the company's performance relative to its peers. The company's revenue is not explicitly broken down by segments or geographic regions in the provided data, but the business is primarily focused on life and health insurance products. The lack of detailed segment information limits the ability to assess the diversification of the company's revenue streams and its exposure to different markets. The growth trajectory of M&G PLC is not clearly defined in the provided data, but the company's operating income of 1.43 billion GBP and net income of 302 million GBP suggest a stable performance. Analysts have provided a range of price targets, with a mean of 300.53 GBP and a median of 295.00 GBP, indicating a generally positive outlook. The mean recommendation of 2.50 suggests a mixed sentiment among analysts, with a balance of buy, hold, and strong-buy ratings. The risk assessment for M&G PLC indicates a medium liquidity risk and a low dilution risk. The company's capital structure, with a high debt-to-equity ratio, may pose a challenge in maintaining financial flexibility, especially in a volatile market environment. The risk of dilution is considered low, which is a positive sign for shareholders. Recent events and filings have not been detailed in the provided data, but the company's financial performance and analyst ratings suggest that it is maintaining a stable position in the market. The company's ability to manage its debt and maintain a positive operating income will be key factors in its future performance.
Key takeaways
  • M&G PLC has a high debt-to-equity ratio of 2.19, indicating a leveraged capital structure.
  • The company's return on equity is 9.63%, which is a positive indicator of profitability.
  • The free cash flow is negative at -174 million GBP, suggesting operational cash outflows or investments.
  • Analysts have provided a range of price targets, with a mean of 300.53 GBP and a median of 295.00 GBP.
  • The company's liquidity risk is assessed as medium, and the dilution risk is low.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyGBP
Revenue
Gross profit
Operating income$1.43B
Net income$302.0M
R&D
SG&A
D&A
SBC
Operating cash flow$953.0M
CapEx-$175.0M
Free cash flow-$174.0M
Total assets$190.60B
Total liabilities$187.47B
Total equity$3.14B
Cash & equivalents$4.52B
Long-term debt$6.87B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.14B
Net cash-$2.35B
Current ratio
Debt/Equity2.2
ROA0.2%
ROE9.6%
Cash conversion3.2%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Life & Health Insurance · cohort 15 companies
MetricMNGActivity
Op margin12.3% medp25 5.6% · p75 21.6%
Net margin2.9% medp25 0.5% · p75 10.1%
Gross margin28.2% medp25 13.4% · p75 30.5%
CapEx / revenue-2.1% medp25 -8.2% · p75 -1.2%
Debt / equity219.0%27.5% medp25 4.7% · p75 66.5%top quartile
Observations
IR observations
Mean price target300.53 GBP
Median price target295.00 GBP
High price target370.00 GBP
Low price target215.00 GBP
Mean recommendation2.50 (1=strong buy, 5=strong sell)
Strong-buy count2.00
Buy count2.00
Hold count8.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.29 GBP
Last actual EPS0.00 GBP
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-22 13:15 UTC#27b52d33
Market quoteclose GBP 315.90 · shares 2.41B diluted
no public URL
2026-05-22 13:15 UTC#c71d537a
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 14:52 UTCJob: 47b1efdd